UK Herald Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Herald Tribune.

Press releases published on October 30, 2026

Oct. 30, 2026

Top Offroad Motorcycle Manufacturer: Shandong Tuowei Locomotive Co., Ltd. Expands Its Market Presence

Indeterminate EIN Presswire

Oct. 30, 2026

Five Reputable Fertilizer Additives Suppliers in China 2026: Advancing Agricultural Nutrient Solutions

Indeterminate EIN Presswire

Oct. 30, 2026

Intelligent Transformation of Foreign Trade: How ECER Is Leveraging AI to Power a New Era of Global Business

Indeterminate EIN Presswire

Oct. 30, 2026

Pukka Unveils Its Bestselling Organic Tea Advent Calendar for Christmas 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

More Than Just Connecting Buyers and Suppliers: ECER Builds a New Mobile Ecosystem for Global B2B Trade

Indeterminate EIN Presswire

Oct. 30, 2026

Five Reputable Hydraulic Fitting Manufacturers in China 2026: Advancing Hydraulic Connection Solutions

Indeterminate EIN Presswire

Oct. 30, 2026

Top Diagnostic Battery Manufacturer Advances iPhone Battery Solutions

Indeterminate EIN Presswire

Oct. 30, 2026

Double Cross Router and Dalgona Switcher: Analog Tools for Complex Rigs

Indeterminate EIN Presswire

Oct. 30, 2026

Analysis of Brineura Market Trends and Forecasts Highlights Significant Long-Term Growth Potential

Indeterminate EIN Presswire

Oct. 30, 2026

New Landlord Insurance Website, Landlord Insurance UK, Launches for UK Property Owners

Indeterminate GlobeNewswire

Oct. 30, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Oct. 30, 2026

Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat

Indeterminate GlobeNewswire

Oct. 30, 2026

Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques

Indeterminate GlobeNewswire

Oct. 30, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

Indeterminate GlobeNewswire